# Nuclide record uk-duesseldorf (institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/institutions/uk-duesseldorf/>
  a schema:MedicalOrganization ;
  nuclide:kind "institution" ;
  schema:identifier "uk-duesseldorf" ;
  schema:name "University Hospital Düsseldorf / CIO Düsseldorf"@en ;
  schema:alternateName "Universitätsklinikum Düsseldorf"@en, "UKD"@en, "Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf"@en ;
  schema:description "Düsseldorf's university hospital, a partner in the CIO cancer centre alliance and a leading site for FAPI and PSMA imaging under Frederik Giesel."@en ;
  schema:url <https://nuclide.cc/institutions/uk-duesseldorf/>, <https://www.uniklinik-duesseldorf.de> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.uniklinik-duesseldorf.de> ;
  schema:addressCountry "DE" ;
  schema:addressLocality "Düsseldorf" ;
  schema:latitude "51.194"^^xsd:decimal ;
  schema:longitude "6.788"^^xsd:decimal ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/indications/hcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/fapi-pet/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:targets <https://nuclide.cc/targets/fap/>, <https://nuclide.cc/targets/psma/> ;
  nuclide:drugs <https://nuclide.cc/drugs/fap-2286/>, <https://nuclide.cc/drugs/pluvicto/> ;
  nuclide:institutions <https://nuclide.cc/institutions/heidelberg-nct/> ;
  nuclide:people <https://nuclide.cc/people/frederik-giesel/> .